These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26724896)

  • 1. The influence of medical burden severity and cognition on functional competence in older community-dwelling individuals with schizophrenia.
    Tsoutsoulas C; Mulsant BH; Kalache SM; Kumar S; Ghazala Z; Voineskos AN; Butters MA; Menon M; Rajji TK
    Schizophr Res; 2016 Feb; 170(2-3):330-5. PubMed ID: 26724896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An optimal combination of MCCB and CANTAB to assess functional capacity in older individuals with schizophrenia.
    Kumar S; Mulsant BH; Tsoutsoulas C; Ghazala Z; Voineskos AN; Bowie CR; Rajji TK
    Int J Geriatr Psychiatry; 2016 Oct; 31(10):1116-23. PubMed ID: 27428251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metacognition and social function in schizophrenia: associations of mastery with functional skills competence.
    Lysaker PH; McCormick BP; Snethen G; Buck KD; Hamm JA; Grant M; Nicolò G; Dimaggio G
    Schizophr Res; 2011 Sep; 131(1-3):214-8. PubMed ID: 21745724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior.
    Bowie CR; McGurk SR; Mausbach B; Patterson TL; Harvey PD
    Am J Psychiatry; 2012 Jul; 169(7):710-8. PubMed ID: 22581070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.
    Keefe RS; Fox KH; Harvey PD; Cucchiaro J; Siu C; Loebel A
    Schizophr Res; 2011 Feb; 125(2-3):161-8. PubMed ID: 21075600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
    Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
    J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of aging, cognition, and symptoms on functional competence in individuals with schizophrenia across the lifespan.
    Kalache SM; Mulsant BH; Davies SJ; Liu AY; Voineskos AN; Butters MA; Miranda D; Menon M; Kern RS; Rajji TK
    Schizophr Bull; 2015 Mar; 41(2):374-81. PubMed ID: 25103208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures.
    Bowie CR; Leung WW; Reichenberg A; McClure MM; Patterson TL; Heaton RK; Harvey PD
    Biol Psychiatry; 2008 Mar; 63(5):505-11. PubMed ID: 17662256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.
    Keefe RS; Poe M; Walker TM; Kang JW; Harvey PD
    Am J Psychiatry; 2006 Mar; 163(3):426-32. PubMed ID: 16513863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergic burden in schizophrenia and ability to benefit from psychosocial treatment programmes: a 3-year prospective cohort study.
    O'Reilly K; O'Connell P; Donohoe G; Coyle C; O'Sullivan D; Azvee Z; Maddock C; Sharma K; Sadi H; McMahon M; Kennedy HG
    Psychol Med; 2016 Nov; 46(15):3199-3211. PubMed ID: 27576609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive competence impairment and cognitive deficits in acutely ill schizophrenia patients residing in nursing homes.
    Adelsky MB; Bowie CR; Goldberg TE; Serper MR
    Am J Geriatr Psychiatry; 2011 Aug; 19(8):752-6. PubMed ID: 21788925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia.
    Ang MS; Abdul Rashid NA; Lam M; Rapisarda A; Kraus M; Keefe RSE; Lee J
    J Clin Psychopharmacol; 2017 Dec; 37(6):651-656. PubMed ID: 29016375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment.
    McCleery A; Ventura J; Kern RS; Subotnik KL; Gretchen-Doorly D; Green MF; Hellemann GS; Nuechterlein KH
    Schizophr Res; 2014 Aug; 157(1-3):33-9. PubMed ID: 24888526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrapyramidal symptoms and cognitive test performance in patients with schizophrenia.
    Fervaha G; Agid O; Takeuchi H; Lee J; Foussias G; Zakzanis KK; Graff-Guerrero A; Remington G
    Schizophr Res; 2015 Feb; 161(2-3):351-6. PubMed ID: 25471015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community outcome in cognitively normal schizophrenia patients.
    Muharib E; Heinrichs RW; Miles A; Pinnock F; McDermid Vaz S; Ammari N
    J Int Neuropsychol Soc; 2014 Sep; 20(8):805-11. PubMed ID: 25083826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia.
    Lin CH; Huang CL; Chang YC; Chen PW; Lin CY; Tsai GE; Lane HY
    Schizophr Res; 2013 May; 146(1-3):231-7. PubMed ID: 23478155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motivational deficits and cognitive test performance in schizophrenia.
    Fervaha G; Zakzanis KK; Foussias G; Graff-Guerrero A; Agid O; Remington G
    JAMA Psychiatry; 2014 Sep; 71(9):1058-65. PubMed ID: 25075930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population.
    Wu JQ; Chen DC; Tan YL; Xiu MH; De Yang F; Soares JC; Zhang XY
    Psychiatry Res; 2016 Apr; 238():196-202. PubMed ID: 27086233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional outcomes in schizophrenia: understanding the competence-performance discrepancy.
    Gupta M; Bassett E; Iftene F; Bowie CR
    J Psychiatr Res; 2012 Feb; 46(2):205-11. PubMed ID: 21944429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.